McMillin D - Search Results

1

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.

Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, Dastur A, Amzallag A, Ramaswamy S, Tesar B, Jenkins CE, Hannett NM, McMillin D, Sanda T, Sim T, Kim ND, Look T, Mitsiades CS, Weng AP, Brown JR, Benes CH, Marto JA, Young RA, Gray NS. Kwiatkowski N, et al. Among authors: mcmillin d. Nature. 2014 Jul 31;511(7511):616-20. doi: 10.1038/nature13393. Epub 2014 Jun 22. Nature. 2014. PMID: 25043025 Free PMC article.

2

Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.

Mitsiades CS, Poulaki V, Fanourakis G, Sozopoulos E, McMillin D, Wen Z, Voutsinas G, Tseleni-Balafouta S, Mitsiades N. Mitsiades CS, et al. Among authors: mcmillin d. Clin Cancer Res. 2006 Jun 15;12(12):3705-12. doi: 10.1158/1078-0432.CCR-05-2493. Clin Cancer Res. 2006. PMID: 16778096

3

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. Mitsiades CS, et al. Among authors: mcmillin d. J Clin Endocrinol Metab. 2006 Oct;91(10):4013-21. doi: 10.1210/jc.2005-2472. Epub 2006 Jul 18. J Clin Endocrinol Metab. 2006. PMID: 16849420

4

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N. Mitsiades CS, et al. Among authors: mcmillin dw. Mol Cancer Ther. 2007 Mar;6(3):1070-8. doi: 10.1158/1535-7163.MCT-06-0449. Mol Cancer Ther. 2007. PMID: 17363500

5

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.

Weisberg E, Kung AL, Wright RD, Moreno D, Catley L, Ray A, Zawel L, Tran M, Cools J, Gilliland G, Mitsiades C, McMillin DW, Jiang J, Hall-Meyers E, Griffin JD. Weisberg E, et al. Among authors: mcmillin dw. Mol Cancer Ther. 2007 Jul;6(7):1951-61. doi: 10.1158/1535-7163.MCT-06-0810. Mol Cancer Ther. 2007. PMID: 17620426

6

Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

Mitsiades CS, Hayden P, Kotoula V, McMillin DW, McMullan C, Negri J, Delmore JE, Poulaki V, Mitsiades N. Mitsiades CS, et al. J Clin Endocrinol Metab. 2007 Dec;92(12):4845-52. doi: 10.1210/jc.2007-0942. Epub 2007 Sep 11. J Clin Endocrinol Metab. 2007. PMID: 17848408

7

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.

Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMillin D, Miller JW, Mitsiades N. Poulaki V, et al. Among authors: mcmillin d. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4706-19. doi: 10.1167/iovs.06-1147. Invest Ophthalmol Vis Sci. 2007. PMID: 17898295

8

The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.

Mitsiades CS, McMillin DW, Klippel S, Hideshima T, Chauhan D, Richardson PG, Munshi NC, Anderson KC. Mitsiades CS, et al. Among authors: mcmillin dw. Hematol Oncol Clin North Am. 2007 Dec;21(6):1007-34, vii-viii. doi: 10.1016/j.hoc.2007.08.007. Hematol Oncol Clin North Am. 2007. PMID: 17996586 Review.

9

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.

Weisberg E, Wright RD, McMillin DW, Mitsiades C, Ray A, Barrett R, Adamia S, Stone R, Galinsky I, Kung AL, Griffin JD. Weisberg E, et al. Among authors: mcmillin dw. Mol Cancer Ther. 2008 May;7(5):1121-9. doi: 10.1158/1535-7163.MCT-07-2331. Epub 2008 Apr 29. Mol Cancer Ther. 2008. PMID: 18445657 Free PMC article.

10

Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib.

Mitsiades CS, Hideshima T, Chauhan D, McMillin DW, Klippel S, Laubach JP, Munshi NC, Anderson KC, Richardson PG. Mitsiades CS, et al. Among authors: mcmillin dw. Semin Hematol. 2009 Apr;46(2):166-75. doi: 10.1053/j.seminhematol.2009.02.003. Semin Hematol. 2009. PMID: 19389500 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page